Contraindicated in:
Use Cautiously in:
GI: worsening hepatic function/hepatitis.
GU: renal impairment.
Hemat: hemolysis/hemolytic anemia.
Local: injection site reactions.
Misc: infusion reactions, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS).
Drug-Drug:
Treatment of Esophageal Candidiasis
Treatment of Candidemia/Acute Disseminated Candidiasis/Candida Peritonitis and Abscesses
Treatment of Candidemia/Acute Disseminated Candidiasis/Candida Peritonitis and Abscesses Without Meningoencephalitis and/or Ocular Dissemination
Prophylaxis of Candida Infections During Hematopoetic Stem Cell Transplantation.
Spectrum:
Absorption: IV administration results in complete bioavailability.
Distribution: Primarily distributed into lung, liver, and spleen; minimal distribution to CNS and eyes.
Protein Binding: >99%.
Metabolism/Excretion: Mostly metabolized in the liver; 71% fecal elimination.
Half-life: 15 hr.
NDC Code*